Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IPHA
Stock Latest News
The Fly
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
11d ago
IPHA
Premium
The Fly
Innate Pharma initiated with a Buy at Lucid Capital
17d ago
IPHA
Premium
The Fly
Innate Pharma management to meet with BTIG
1M ago
IPHA
Premium
The Fly
Innate Pharma management to meet with BTIG
1M ago
IPHA
Premium
The Fly
Target initiated, Nike upgraded: Wall Street’s top analyst calls
2M ago
DG
HD
Premium
The Fly
Innate Pharma downgraded to Neutral from Buy at H.C. Wainwright
2M ago
IPHA
Premium
Company Announcements
Innate Pharma SA Reports First Half 2025 Financial Results
2M ago
IPHA
Premium
Ratings
Innate Pharma’s Strategic Shift and Financial Challenges Lead to Hold Rating
2M ago
IPHA
Premium
The Fly
Innate Pharma downgraded to Market Perform from Outperform at Leerink
2M ago
IPHA
Premium
The Fly
Innate Pharma initiated with a Buy at BTIG
3M ago
IPHA
Premium
Company Announcements
Innate Pharma’s IPH4502 Study: A New Hope in Cancer Treatment
4M ago
IPHA
Premium
The Fly
Innate Pharma presents preclinical data for IPH6501 at EHA
5M ago
IPHA
Premium
The Fly
Innate Pharma presents long-term follow-up data from TELLOMAK trial
6M ago
IPHA
Premium
Ratings
Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
7M ago
IPHA
Premium
The Fly
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
7M ago
IPHA
Premium
The Fly
Innate Pharma announces EUR 15M capital increase from Sanofi
7M ago
SNY
IPHA
Premium
The Fly
Innate Pharma regains rights to Anket, announces potential Sanofi investment
7M ago
SNY
IPHA
Premium
Ratings
Innate Pharma: Promising Pipeline and Strategic Developments Drive Buy Rating
8M ago
IPHA
Premium
Company Announcements
Innate Pharma Reports 2024 Financial Results and Clinical Progress
8M ago
IPHA
Premium
Ratings
Buy Rating for Innate Pharma: Lacutamab’s Breakthrough Designation and Market Potential Drive Positive Outlook
9M ago
IPHA
Premium
Ratings
Innovative Potential of Innate Pharma’s IPH4502 in Overcoming Drug Resistance and Expanding Therapeutic Impact
9M ago
IPHA
Premium
The Fly
Innate Pharma doses first patient in IPH4502 study
10M ago
IPHA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
